Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?

Nuclear medicine, scientific publishing and the era of cost containment

(2011) Ignasi Carrió   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours?

(2011) Akram Al-Ibraheem et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

(2011) Lisa Bodei et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Incidence of Increased 68Ga-DOTANOC Uptake in the Pancreatic Head in a Large Series of Extrapancreatic NET Patients Studied with Sequential PET/CT

(2011) P. Castellucci et al.   JOURNAL OF NUCLEAR MEDICINE

Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant Insulinomas

(2011) D. Wild et al.   JOURNAL OF NUCLEAR MEDICINE

Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease

(2010) Irvin M. Modlin et al.   ANNALS OF SURGICAL ONCOLOGY

68Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours

(2010) Valentina Ambrosini et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE

(2010) Irene Virgolini et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors

(2010) V. Ambrosini et al.   JOURNAL OF NUCLEAR MEDICINE

Evaluation of chromogranin A determined by three different procedures in patients with benign diseases, neuroendocrine tumors and other malignancies

(2010) Rafael Molina et al.   TUMOR BIOLOGY

Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy

(2009) D. Putzer et al.   JOURNAL OF NUCLEAR MEDICINE

Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer

(2008) Michele Malaguarnera et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Plasma chromogranin a in patients with inflammatory bowel disease

(2008) Valentina Sciola et al.   INFLAMMATORY BOWEL DISEASES

Psychological Stress Evaluation of Patients with Bronchial Asthma Based on the Chromogranin A Level in Saliva

(2008) Ken Hoshino et al.   JOURNAL OF ASTHMA

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: An immunohistochemical and ultrastructural study

(2008) Maya Gulubova et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Effect of exercise training on chromogranin A and relationship to N-ANP and inflammatory cytokines in patients with chronic heart failure

(2007) Alf Inge Larsen et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY